Abstract

As the number of people diagnosed with Alzheimer's disease (AD) reaches epidemic proportions, there is an urgent need to develop effective treatment strategies to tackle the social and economic costs of this fatal condition. Dozens of candidate therapeutics are currently being tested in clinical trials, and compounds targeting the aberrant accumulation of tau proteins into neurofibrillary tangles (NFTs) are the focus of substantial current interest. Reliable, translatable biomarkers sensitive to both tau pathology and its modulation by treatment along with animal models that faithfully reflect aspects of the human disease are urgently required. Magnetic resonance imaging (MRI) is well established as a valuable tool for monitoring the structural brain changes that accompany AD progression. However the descent into dementia is not defined by macroscopic brain matter loss alone: non-invasive imaging measurements sensitive to protein accumulation, white matter integrity and cerebral haemodynamics probe distinct aspects of AD pathophysiology and may serve as superior biomarkers for assessing drug efficacy. Here we employ a multi-parametric array of five translatable MRI techniques to characterise the in vivo pathophysiological phenotype of the rTg4510 mouse model of tauopathy (structural imaging, diffusion tensor imaging (DTI), arterial spin labelling (ASL), chemical exchange saturation transfer (CEST) and glucose CEST). Tau-induced pathological changes included grey matter atrophy, increased radial diffusivity in the white matter, decreased amide proton transfer and hyperperfusion. We demonstrate that the above markers unambiguously discriminate between the transgenic group and age-matched controls and provide a comprehensive profile of the multifaceted neuropathological processes underlying the rTg4510 model. Furthermore, we show that ASL and DTI techniques offer heightened sensitivity to processes believed to precede detectable structural changes and, as such, provides a platform for the study of disease mechanisms and therapeutic intervention.

Highlights

  • Alzheimer's disease (AD) is a continuum of relentless irreversible biochemical and pathological changes that lead to pronounced neurodegeneration

  • We demonstrate that arterial spin labelling (ASL) and diffusion tensor imaging (DTI) metrics are sensitive to tau-pathology in regions of low neurofibrillary tangles (NFTs) density prior to significant atrophy, providing evidence that these data may inform the development of a multi-parametric imaging biomarker for early detection of tau pathology in the clinic

  • This study reports the first application of non-invasive imaging biomarkers, sensitive to perfusion, protein accumulation, glucose uptake and tissue microstructure to generate a multi-parametric tissue characterisation of tau pathology

Read more

Summary

Introduction

Alzheimer's disease (AD) is a continuum of relentless irreversible biochemical and pathological changes that lead to pronounced neurodegeneration. J.A. Wells et al / NeuroImage 111 (2015) 369–378 impeded proton exchange that may occur due to the presence of aggregated protein. The CEST method saturates mobile protons of the macromolecular pool that are exchanging with the bulk water pool (for recent reviews see Liu et al, 2013; van Zijl and Yadav, 2011). In this study we used CEST to probe amide -proton transfer in grey matter structures. We implemented diffusion tensor imaging (DTI) (a sensitive measure of local tissue inflammation and cellular integrity) to probe changes in microstructural compartmentation. We applied arterial spin labelling (ASL) and glucose CEST (glucoCEST) to measure perfusion and glucose delivery and uptake to infer changes in cerebral metabolism, vasculature and neuronal excitability and compare these measures to the more established structural MRI biomarkers and histology

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.